ÂÜÀòÂÒÂ×

Michaelyn Lux is a Principal Scientist at Pfizer since August 2024, previously serving as a Senior Scientist at Merck from June 2019 to June 2024. Prior to that role, Michaelyn Lux worked as a Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center from July 2014 to June 2019, focusing on the development of methods to synthesize the pyrano[3,2-b]benzofuran motif, essential for various bioactive natural products. Michaelyn Lux started the academic journey at Michigan State University, working as an Economics Teaching Assistant and a student researcher in the Jackson Lab, along with gaining research experience during an REU summer at The University of Southern Mississippi. Education includes a PhD from Joan & Sanford I. Weill Medical College of Cornell University and a Bachelor of Science in Chemistry from Michigan State University.